Ambu joins green climate initiative

The Danish medical tech firm now joins climate initiative Science Based Targets, which by setting a series of green objectives seeks to help mitigate climate change, aiming to limit global heating to below 1.5 degrees Celsius relative to the pre-industrial average.

BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY DANIEL FRANK CHRISTENSEN

Published: 17.08.21 at 12:38

Medical technology company Ambu, based in Copenhagen suburb Ballerup, joins the Science Based Targets initiative (SBTi), the purpose of which is to help mitigate climate change by setting a series of green goals, shows Ambu's third-quarter interim report.

The firm thus enters the company of numerous other domestic businesses, which in recent years have signed up to the initiative, including WS Audiology, Lundbeck, DSV Panalpina, A.P. Møller-Mærsk, FLSmidth, Velux and Carlsberg.

Already a subscriber? Log in.

Read the whole article

Get 14 days free access.
No credit card required.

Access all locked articles
Receive our daily newsletters
Access our app

Start a free company trial today

"Real world" patient data documents the long-term effects of ALK vaccines

Data from ALK's React study, which is a retrospective real-world evidence study including more than 92,000 patients with respiratory allergies, have just been published in the journal The Lancet Regional Health – Europe. | Foto: ALK / PR

In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers.